Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wei-Xin Liu
Mucosal Healing Did Not Predict Sustained Clinical Remission in Patients With IBD After Discontinuation of One-Year Infliximab Therapy
PLoS ONE
Multidisciplinary
Related publications
Adalimumab Discontinuation in Patients With Rheumatoid Arthritis After Achieving Sustained Remission
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Association of Sleep Quality and Mucosal Healing in Patients With Inflammatory Bowel Disease in Clinical Remission
Annals of Gastroenterology
Prediction of Relapse After Discontinuation of Infliximab Therapy in Severe Sarcoidosis
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Comment on ‘Sustained Discontinuation of Infliximab With a Raising-Dose Strategy After Obtaining Remission in Patients With Rheumatoid Arthritis: The RRRR Study, a Randomised Controlled Trial’ by Tanaka Et Al
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Infusion Reactions Related to Infliximab Therapy Are Not Usually Associated With Drug Discontinuation
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Spontaneous Remission of Marginal Zone B Cell Lymphoma in a Patient With Seropositive Rheumatoid Arthritis After Discontinuation of Infliximab-Methotrexate Treatment
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-Making for IBD Outpatients on Maintenance Infliximab Therapy
Inflammatory Bowel Diseases
Allergy
Immunology
Gastroenterology
Long-Lasting Remission of Severe Behcet's Disease After the End of Infliximab Therapy
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Correction: Discontinuation of Adalimumab After Achieving Remission in Patients With Established Rheumatoid Arthritis: 1-Year Outcome of the HONOR Study: Table 3
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics